NCT06302595Recruiting
MRI Guided Prostate Biopsy
Magnetic Resonance Imaging Guided Prostate Biopsy
Source: ClinicalTrials.gov · Last updated 3 Dec 2025
Brief summary (registry, in English)
This study aims to assess the feasibility of magnetic resonance (MR) guided prostate biopsy using a needle holder frame. This frame is used to help position the needle used for the biopsy. The feasibility in this study is defined as whether the needle holder frame enables accurate tissue sampling from a suspicious region in the prostate found on an MR image. If it does, a biopsy can be carried out with the needle holder frame safely in a clinical routine. The study will be conducted during a routine MR-guided prostate biopsy procedure with an investigational needle holder frame instead of a conventional needle-guiding template.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 15 (estimated)
- First submitted
- 15 Feb 2024
- Start date
- 24 Aug 2023
- Primary completion date
- Jun 2026
- Lead sponsor
- Brigham and Women's Hospital
- Diseases
- Prostate cancer
- NCT number
- NCT06302595
What you commit to
- Study type: Interventional
- Planned participants: 15
- From 24 Aug 2023 to the primary completion date, Jun 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Contra-indications to MRI- cardiac pacemaker, inner ear implants, non-MR compatible intracranial aneurysm clips.
- Recent or ongoing active ischemic heart disease such as recent or ongoing angina.
Other
- Inability to give informed consent.
Who the study is looking for
- Either an abnormal serum prostate-specific antigen (PSA) level (\> 4ng/Ml) or a palpable nodule in the prostate on digital rectal examination or prostate MRI suspicious lesion..
- Diagnostic MRI of the prostate gland.
- Age \> 30 years
- Signed informed consent.
- No contra-indications to MRI, i.e. no cardiac pacemaker.
- No recent or ongoing active ischemic heart disease.
Age in the registry: 30 years to - · Sex: Male · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Brigham and Women's Hospital Coordinator of this site? Confirm its status | Boston | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.